Novel Piperidinyl-triazinyl-phenols for the Treatment of Inflammatory Diseases including Alzheimer’s and Parkinson’s Diseases

Abstract A series of 3-piperidyl-amino-l,2,4-triazin-6-yl-phenol analogs is described as inhibitors of NLRP3. NLR proteins are involved in the immune system. The activated NLRP3 protein assembles with other proteins into inflammasomes leading to downstream proteolytic events including the formation of proinflammatory cytokines such as IL-1B and IL 18. Inhibition of NLRP3 represents a potential treatment for multiple inflammatory diseases including Alzheimer’s disease, Parkinson’s disease nonalcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), metabolic dysfunction-associated Steatohepatitis (MASH), and multiple sclerosis.

Authors

Institutions

Publication Details

Journal
ACS Medicinal Chemistry Letters
Published
2026-11-16
DOI
https://doi.org/10.1021/acsmedchemlett.6c00582
Primary Topic
Inflammasome and immune disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Novel Piperidinyl-triazinyl-phenols for the Treatment of Inflammatory Diseases including Alzheimer’s and Parkinson’s Diseases

Gérard Rossé
1 links
ACS Medicinal Chemistry Letters
Inflammasome and immune disorders
article

Novel Piperidinyl-triazinyl-phenols for the Treatment of Inflammatory Diseases including Alzheimer’s and Parkinson’s Diseases

Gérard Rossé
article en

Abstract

Abstract A series of 3-piperidyl-amino-l,2,4-triazin-6-yl-phenol analogs is described as inhibitors of NLRP3. NLR proteins are involved in the immune system. The activated NLRP3 protein assembles with other proteins into inflammasomes leading to downstream proteolytic events including the formation of proinflammatory cytokines such as IL-1B and IL 18. Inhibition of NLRP3 represents a potential treatment for multiple inflammatory diseases including Alzheimer’s disease, Parkinson’s disease nonalcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), metabolic dysfunction-associated Steatohepatitis (MASH), and multiple sclerosis.

ACS Medicinal Chemistry Letters
World Trade Organization (CH)
Good health and well-being
Inflammasome and immune disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon